I
I. Gillespie
Researcher at Edinburgh Royal Infirmary
Publications - 21
Citations - 1906
I. Gillespie is an academic researcher from Edinburgh Royal Infirmary. The author has contributed to research in topics: Angioplasty & Randomized controlled trial. The author has an hindex of 16, co-authored 21 publications receiving 1749 citations. Previous affiliations of I. Gillespie include University of Edinburgh.
Papers
More filters
Journal ArticleDOI
Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: An intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy
Andrew W. Bradbury,Andrew W. Bradbury,Donald J. Adam,Jocelyn Bell,John F. Forbes,F. Gerry R. Fowkes,I. Gillespie,C. V. Ruckley,Gillian M. Raab,Basil trial participants +9 more
TL;DR: Overall, there was no significant difference in AFS or OS between the two strategies, however, for those patients who survived for at least 2 years after randomization, a BSX-first revascularization strategy was associated with a significant increase in subsequent OS and a trend towards improved AFS.
Journal ArticleDOI
Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: Analysis of amputation free and overall survival by treatment received
Andrew W. Bradbury,Andrew W. Bradbury,Donald J. Adam,Jocelyn Bell,John F. Forbes,F. Gerry R. Fowkes,I. Gillespie,C. V. Ruckley,Gillian M. Raab +8 more
TL;DR: BSX with vein offers the best long term AFS and OS and, overall, BAP appears superior to prosthetic BSX, which is associated with a significantly higher early failure rate than BSX.
Journal ArticleDOI
Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: A survival prediction model to facilitate clinical decision making.
Andrew W. Bradbury,Andrew W. Bradbury,Donald J. Adam,Donald J. Adam,Jocelyn Bell,John F. Forbes,F. Gerry R. Fowkes,I. Gillespie,C. V. Ruckley,Gillian M. Raab +9 more
TL;DR: It may be possible to define the clinical and anatomic characteristics of SLI patients who are likely-and not likely-to live for >2 years after intervention as an aid to clinical decision making.
Journal ArticleDOI
Is intermittent claudication improved by percutaneous transluminal angioplasty? A randomized controlled trial.
Mark R. Whyman,F. G. R. Fowkes,E.M.G. Kerracher,I. Gillespie,Amanda J Lee,E. Housley,C. V. Ruckley +6 more
TL;DR: Patients with mild and moderate intermittent claudication after PTA had less extensive disease than medically treated patients, but this did not translate into a significant advantage in terms of improved walking or quality of life after 2 years.
Journal ArticleDOI
Multicentre randomised controlled trial of the clinical and cost-effectiveness of a bypass-surgery-first versus a balloon-angioplasty-first revascularisation strategy for severe limb ischaemia due to infrainguinal disease. The Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial
Andrew W. Bradbury,Donald J. Adam,Jocelyn Bell,John F. Forbes,F. G. R. Fowkes,I. Gillespie,Gillian M. Raab,C. V. Ruckley +7 more
TL;DR: The findings of this study suggest that in patients with SLI due to infrainguinal disease the decision whether to perform bypass surgery or balloon angioplasty first appears to depend upon anticipated life expectancy.